Clinical Trial: Lawyer’s Prostate Cancer Now Undetectable

Print icon

When Gordon Cleland found out he had advanced prostate cancer in January 2017, he said he would do whatever it took to beat the disease.

An avid runner and swimmer, the 68-year-old attorney said he was prepared physically to take on the rigors of surgery and treatment.

“Truth be told, when I heard my PSA score [of 16], I had some fears about what that would portend and they proved to be correct,” he said. “I did my best to motivate myself to get treated as quickly as I could.”

His first task was finding a top urologic surgeon to remove the cancer. Cleland, who had also recently successfully battled melanoma, asked a provider from another health system for the name of the best urologist in the region.

His answer: Hartford HealthCare Tallwood Urology & Kidney Institute’s Dr. Joseph Wagner.

“I’m a lawyer,” said Cleland, “so when you get competitors recommending people who are not associated with their firm or their hospital, that means something to me. The guy must be really good.”

Cleland, from Monroe, made the 50-minute drive to Dr. Wagner’s Farmington office to discuss his options for surgery. Typically, a patient with metastatic prostate cancer doesn’t undergo a prostatectomy — surgery to remove part or all the cancerous prostate gland. For decades, doctors believed the procedure wouldn’t be effective if the cancer had already spread to other parts of the body.

“That didn’t make sense to me,” said Cleland. “I expressed that to Dr. Wagner. He listened to me and started doing some research and speaking to his peers.”

Through the Hartford HealthCare Cancer Institute’s membership in the Memorial Sloan Kettering Cancer Alliance, Dr. Wagner found that Cleland would be a candidate for a recent MSK study.

“Under the study, when there are metastasis to just a few sites, patients undergo androgen deprivation therapy (injections to lower the male hormone testosterone) and radiation to the metastatic sites,” said Dr. Wagner, director of robotic urologic surgery at Hartford Hospital. “The patient goes on to have a prostatectomy. He was a perfect candidate. So we applied the protocol from MSK here locally and he did great.”

Prior to his surgery in late May 2017, Cleland received radiation treatments at Hartford Hospital under the direction of Dr. Andrew Salner, medical director of the Hartford HealthCare Cancer Institute at Hartford Hospital. Dr. Salner said when the cancer has spread to only a limited amount of sites, like in Cleland’s case, those areas can be treated effectively using three to five highly focused sessions of stereotactic body radiation therapy, generally with few side effects.

“A team of highly specialized physicists and dosimetrists utilize sophisticated software to plan the treatment, and advanced linear accelerator technology not available at most locations facilitates the treatment delivery,” said Dr. Salner.

Following an eight-week course of daily radiation to the prostate bed at a hospital closer to his home, Cleland’s cancer was declared undetectable in August of 2017. He continues to see Dr. Wagner and his oncologist in Fairfield County for routine monitoring.

“I do not now have any detectable cancer, but I’m ready for any further challenge,” said Cleland. “Even if this whole experience only adds one additional year to my life, it will all have been worth it.”

For information about the Memorial Sloan Kettering Cancer Alliance, click here. For information about Tallwood Men’s Health, click here.


What's New

Anger

Why People, And Medical Researchers, Need Help with Anger

Anger is the first negative emotion babies can express and research shows that as many people seek treatment for it as depression and anxiety combined. Yet it is not officially classified a mental health disorder which, according to Dr. Ray DiGuiseppe, director of education with the Albert Ellis Institute and...


High Preparedness: Legal or Not, What’s Weed Do to Drivers?

Dr. Godfrey Pearlson Director, Olin Neuropsychiatry Research Center at the Institute of Living Research Director, Institute of Living Hartford HealthCare Behavioral Health Network Whatever the outcome of the current debate on legalizing recreational marijuana in Connecticut, we need to know more about marijuana’s overall effect on the brain and behavior...

Stress and Your Heart

Study: Stress-Related Disorder Heightens Heart Risk

People have a 60 percent increased risk of cardiovascular disease within the first year of being diagnosed with any stress-related disorder, according to a new study in Sweden. The results, published April 10 in the British Medical Journal, used data from the Swedish National Patient Register to compare people diagnosed...

Joint Replacement Surgery

Why a Partial Knee Replacement is Same-Day Surgery

Doctors at the Hartford HealthCare Bone & Joint Institute at Hartford Hospital are using new technology to customize joint replacements, making recovery easier. Here’s more from Dr. Mark Shekhman, a Bone & Joint Institute orthopedic surgeon: Q: At the bone and joint institute you use tools to assess the best route...